SlideShare une entreprise Scribd logo
1  sur  18
Télécharger pour lire hors ligne
!"#"$ %&'()*+),-+.$#/(,012
3456$)7839&0:3456$)7,-+.$1+" "9# "99$3 1+" "9# 132*/$41)
;9#/( )!"< 3:/=>62+%"" 2 #)6+,-+.$1+ %4%6 283963%3 +:/
=>67%%"%3:"%?&5)!"< 37%" "9# %46"@1(%$0 2A BCDEF D
GDDEFH &'( I J KFL#/( >#)6+%42M$98#"%&+,-+.$ N:032M 2 5
O3%"":7'72%47%"":%"72%"$:"-+) ,-+.$#/(:/N2+" '5<@()*+ 8$# "0$:%)
PIQO3O 1"R ,-+.$ % M*%"":839 S"%"":6$)7
;9,-+72#
TU% VWWT
V
! "#
!$% & '
X เ<@( 8$# )%"2-83,-+.$#/(N2+" 393 34(:3@2%4 2)6+:/"94#Y4M<
,-+.$ 32M32M$98#"%&+
VX <@( 8$# )6+7+6 +#/()6 0$ O3%"":#" %;ZR0[KA [ E
E] ^DK EH
TX <@( 8$# )%""%?839%"< 3<@(8%+=>68 6 $4**/<
(#
X ,-+.$63,0123456$)7#/(7 1+" "9# 393 34(:3@2N2+-%1+ :"
$ S:0[KN2+1:%;ZR#/(%6 2AM )!"< 3$ S:[K T 839,-+.$
63,012:%%$0V_ $:K` D] $ S:[K WH :/8$# %"2-83,-+.$#/(:/M$9
ECDEF 0[K:%%$0%;ZR#/(%6 2
VX 32M$98#"%&+7%%"" "9# 393 34(:3@2%4 2#/("S8" N2+8%0
I a ]E
TX ,-+.$#/(N2+" 393 34(:3@2 :"72%"% =>6N2+2+$1 !272%3S0:2-83
,-+.$8 6 $4**/< APE EJ bbEJH
!)"
` 1"[Kc T 63,0123456$)7)!"< 3%;ZR%6 2c VUdA7 $,-+.$ [Kc T e
7 $,-+.$#/(N2+" 393 34(:3@2: !"< 3)810392@ H
` 1"[Kc W 63,0123456$)7:%%$0V_ $%3:K ` D] c VUdA7 $,-+.$[K
cW e7 $,-+.$#/(N2+" 393 34(:3@2: K` D] )!"< 3810392@ H
` 1"%"%42M$98#"%&+#/("S8",37% ECDEF
` I a ]E c UdA7 $,-+.$#/(%42 %"e7 $,-+.$#/(N2+" 393 34(:
3@2: K` D] 63,0123456$)7810392@ H
` %42753@21:1$ 3@2 %1:N"f=cVUdA7 $,-+.$#/(:/%"e7 $,-+.$#/(
N2+" 393 34(:3@2: !"< 363,0123456$)7810392@ H
T
*+,-./001,2
gKBP DO3%"":%0,012AhiV jhiTH DO3%"":63,012"99$4%k1A[IGH
DO3%"":63,012"99<%flmAnioH 6+,012ABKH M*%"":
# & 34 %563
"0$:42
X<X #$/O%24p !*14$q < ?RO38<#R S; @5AIrBH
X<X *-O%24p %?:O 14p O38<#R S; $ArsH
X X <"6:<" <*"-# 6$6 + %"< 36+,012 S;3441
X X :<" !1t94 6$6 + %"< 3O3%"": S;%47Ar H
;9< 3O3O 1"R uF bJJ S;%47Ar H
%47%"": v6: e:/8$# 72%"=>6)%")6+%"2-83"%?,-+.$#/(N2+" 393 34(:3@2%4
263,0123456$)7
!
%")*+%"9$%"72%"$:"-+)%"8%+N =>6,-+.$N2+" 393 34(:3@2%4 263
,0123456$)7#/(+:"%?)!"< 3
80= "0$:"+
"/ #/
" "S
9#+%3
"0$:w414
$2,3
x
!
$ S:8397268$# w414:@(%42=>67%!"8#"%&+63,-+.$" "9# 393 34(:
3@2%4 2),-+.$63,0123456$)7
7
%"72%"$:"-+ryArEz D ] ] H %"9$%"#/(2 4%""0$:%!2,-+w414
6"@6 0$ 0) R%"<@("+839)*+$:"-+)%"<q )6+:/S;M<839%42,33<YR2/'5
!2 $ -0N%%"<q 6"@,-+w414 839<q { $:"-+ 6 0$ 6"@ R%"2 5%"
72%"$:"-+7' :" :)*+ "@(:@ 06 '()%"8%+=>6 6 0$ #/(%42'5)6+N2+
%"9$%"72%"$:"-+#/(2/839:/%""/"-+"0$:%"96$0 S3%"#/(798%+=>6 !2*0$%3(%" 6"@
"96R$:"-+7%,-+*/($*>8397%1" -0:@6"@ % "$4*%": $:"-+#/(S3%" :" N
)*+)%"# <@(8%+N =>6N2+%"83% 3/( "/"-+%) "@(#/(%6 279%42"9!*R10,-+#/(2
"9 %";R6"@"9 =>68 2/$% :")*+$:"-+#/(N2+N8%+=>6N2+0 -%1+"$2"|$839
%42"9!*R-S210,-+" "4%"10N 6$6 +%3S0: O3O 1"RN2+%6 2! "97 })2+%"
,0123456$)7WUU" i},-+.$630/57 1+" "9# 393 34(:3@2 010 @(132N <@(
v%N:0)6+%4234(:3@2N S21)"9 N63$/ "0% @(7% 2 #/()*+:/63 *42839
63 2*0 2#/()*+VjTjxjW ] 7'#)6+,-+.$%42$:,42<327%%"" "9# @(7%7N:0
N2+3@:" "9# 6"@" "9# &5#)6+%42=>6 %4 2!2)*+$4Y/1"$72-0[K%3S0: 15
N$+$00[K[Kc T %;ZR VUd7%%"~4142@ :%" :%|N2+•WXn d2@ %S:M< YR%|N2+
•xXh d2@ :/ :%|N2+•o d7% 414#/(:/828$!+:323 @(:7%S3%" %3S0:
1"96 %839)6+$: )%"2-83,-+.$%3S0:2%30$!2"0$:%8%+=>6 72#8$# ~414%"
$4Y/" "9# k#Y4 ,3 / %"%42M$98#"%&+!2N2+" $:"0$::@#57%8<#R
< 3M* %% M< 2839%!M* %" v6: <@()6+,-+.$" "9# 0 -%1+839
< : >146"@,-+2-83,-+.$)%+3*42*0$ </(3/5 1@6"@$ S%%%"" "9# )6+N2+,3
2/:%'5
0$) "@(%"9$%"72%"=>6)6+%""%?< 3N2+72#8$# %""%?#5 8<#R
< 3"$:'#/:2-83)6+:/%" N)*+%,-+.$N2+)63 € %";R<@()6+,-+.$ 32M21$ 0#/(
79 10N /5
W
! 8 6 9/:;/:1,+<-:=+>- # # ?@A
,-+.$<O6>4 SVo }63,012y•KJQ•Kb :@($#/(h <k?M :VWW 63,012 $
< =>6 ‚EzI DJE b 1+)*+"@(*0$< S6$)7A[uPH 637%5V $ $#/(_ <k?M :
VWW ,-+.$ %"2/'5 :" B gQQa839z E "@(*0$< S6$)7A[uPH %N2+"4(:"
"9# 393 34(:3@2$#/(o <k?M :VWW !28<#R)6+"4(:" "9# W ] B $
#/(VU<k?M :VWW N2+T ] B $#/(V <k?M :VWW N2+T ] B " T $ 791"$7,3
[K$#/(VV <k?M :VWW $3UhXUU X ,3%"79[K•oXV ,-+.$N:0:/%"8#"%&+ a D
7%$$9)2€
%"2-83"%?#/(N2+") [IG
X BaFCM$9a D
VX " 8<#R"#" # #/8<#R(%""%?,-+.$N2+" • r ]bX • jƒƒPV 839)6+
B 393 34(:3@2V $
TX 1"$7,3[K<@(Kb $3 _XUU X VT <k?M :VWW A1:%;ZR%6 2Kb 6 [K
M ) Vx *:XH ,3N2+[K•Xn " 8<#R(%""%?)6+"4(:" "9# 393 34(:3@2)6:0
xX ,-+.$ %"#S3[K -0) %;ZR#/(%6 28<#R(+,-+.$ %7%[IGN<%"%?1$#/(
Dnio 7+6 +#/(N2+010+:-3"@(%"" "9# 393 34(:3@2 ,-+.$%42 2 <@()6+7+6 +#/(
D„v"9$,-+.$10 @(10N
"S,-+.$ :"76 0%3 +N2+7%%"„v"9$N:0< [KPEE /%
#'#&#!% B
,-+.$" /5,3[K -810N:0:/%"82 M$98#"%&+ *0:/3@2 %1:N"f=:@(:/%"
8"f=63B gQQa&'( w4%4"4#/(N:0N8$# 2/$%,-+.$ 7:/0#/(1(%$0/5%|N2+,3%"
1"$7 7N:0 7"4< 3 [IGN2+" $0:/%"1"$7 1:8$# ~414#/(%6 2 -083+$@
X Kb %"1"$7/%"5" ,3[K•oXV #0"58"%
VX S3%"#/(793@2 2#%?9*0%"2-23@2 %:7% %"""7S)0Qa 3@2
01"$7 N:0:/8$# #/(*27 7%42%" lm "v%%"IE 3@2*0$ "4:k#Y4p
TX )63%%" [IG79793@201"$71 *+!21"$7<"+:%#5IuI uEEDs
uEEDIE839PQiPQQ!22-23@2VUJJ)0Qa 01"$7‚ax Qa %")0Qa N:0:/%"%6 2
$0)0QaN6 %083963!281039Qa79:/"v%%"8|1$ 3@2 -02 /5
`Qa IuI:/"g JJ JJ*0$)6+3@2N:0IE
` Qa uEEDs :/"sED]ƒED v%%"8|1$ 3@2839v%%")*+513
:|23@282
h
` Qa uEEDIEN:0:/"9N"
` QaPQiPQQ:/sED]I v%%"8|1$ 3@2
xX /%"92|6 '(#/(0 "4: 61S#)6+%420[K,42%14@M$9 "0% ,-+.$%/($%!"
1#/(7#)6+%42k#Y4p "393 34(:3@2 3/(83 7%%"1"$7‚a#/(82 :""M<%"
# 1!21"$7u a ,3:%%$0UUU&'(%4%$00%14:% 7#)6+!"1/#/()*+)%"8|1$
3@2#/(1 "+ '5 -0) M<N:0<"+:)*+ %"8|1$ 3@27'*+%$0%14
7 C!
X :/%"1"$7IE ])6:0#S%"5#/(< $00[K ,-+.$ -%40%14839N:0:/%"
8#"%&+!2%"793@2)6:0
VX %"2-23@27% 01"$7[K1+2-23@2<@()6+80)7$0N:0:/ b lm!2
2-23@2 %VUJJ%02-23@201"$7
TX 72#8$# %"""7SQa‚a:@(:/%"1"$73@2IE]b ‚a#S%"5"/322 /5
TX )0QauEEDJE
TXV )0Qa PQiPQQ
TXT )0QaIuI
TXx )0QauEEDs
xX 8<#R7)*+EF 393 34(:3@2323)" #/(:/M$91$ 6"@:/!"1"0$:2+$
! D 6 9/:;/:1,+<-:=+>- # # ?@AE F-G/=.1HI
,-+.$6>4 Sx_ }63,012y•KJ‚ DJE J E :@($#/(VU%"%~ :VWx :/=>6
: !"< 3!"#"$ %:@(VT %S:M< YRVWxT 2+$ %" L8 08" <-2N:0N2+
8<#R(1"$7[K,3Xx 83901"$7IQu ,3< I a JE8<#R)6+%""%?2+$ 839
% M< 2 -0!"< 3 W $ %"2/'5,-+.$"-+'%1$2/<-2N2+8 8|8"8<#R76 0
%3 +$#/(o :/ :VWxT
,-+.$:!"< 3"5/5$#/(x <k?M :VWW 2+$ %"&':3%0:!"< 3T $ <-2N:0
*2:/3@(N+7/ < 753@21:8 ` '!"< 3#/(6+…S%…479[K,3•nXh " 8<#R
# #/
n
%""%?)6+6• r ]b• 8390# IQu ,3< saD ] E] 0 +[IG<@(
)6+%"2-83"%?M$9…S%…483914210K ,-+.$N!"< 3@(<@("%?10) "@(!"# : #/(
71+N2+"%",012 7+6 +#/([IGN2+14210<@(K ,-+.$!2)*+%"9$%"2 /5
X < 3[J z D14210O-R@( "<@(14210!"< 3+ / #S%!"< 3#/(
:",012: N2+!214210#/39!"< 3"4(:7%!"< 3)%3+/%0 *0!"< 3<"9
(%3+!"< 3 "O"2-"!"< 3*3"9# !"< 3M-:4<3
VX 8<#R$"6"@8<#R7+ N+79 S" 39 /2%8<#R !"< 3#/(14210
TX %";/ ,-+.$ 1""9% SM<1+14210 *X <@()6+*0$6!"< 3#/(79" K
,-+.$
xX<-2S%>14!28<#R839< 3#/(2-83<@("+ $: +)7%";/1+K ,-+.$N!"
< 3@(839*/587 4#Y4)%"70 0"%?< 3 4#Y41+ %2 "9% SM< 839"9% :)
!"< 3"{ 3
WX %";/>14N:0:/=>6# %"4 :"14210!"< 3 %* <@(K ,-+.$N"%?10
@(N2+<@()6+,-+.$N2+"%""%?#/("$2"|$
hX :@(14210N2+2 4%"1:51 %"K 1:%148390,-+.$N!2" ]a J
<"+:% 7+6 +#/([IGN%" K 0,-+.$N!"< 3M-:4<3A"$:"99$3)%"14210
K N2+M ) h *($!:H
# & F-;-:
X )0gQQaEƒE†‡FJ 839EˆQa
VX )6+ ‰_ ]X • F 637%5 ‰_ ] • #S%_ *:
TX Š ‰WU]X • #S%_ *:X
xX ƒƒPV •
WX EaFC•isjis
&%IF /5:"14210K N2+!2!"< 3M-:4<3",-+.$ @(7%,-+.$:/1""9%
SM<#/(!"< 3M-:4<363K ,-+.$N "%""%?1083+$7+6 +#/([IGN2+!#"1421:,3%"
"%?)$10:#" $0,-+.$N2+"%",012: saD ] E] 63,0122/'5•isFa 2/
=77S <%flm -0 DY"":2"-+'%1$2/<-2SN2+8 ` 8|8"2/
%";//5< $00[K -!2 :< YR% %"8#"%&+#/(%42'57%"9 %";R 1$ 0#/(
#)6+7+6 +#/([IGN2+1"$7[K&5T "5!2 793@27%1$,-+.$ @ N2+$00[K -7"4
_
$4"96R 61S$0#N:'%42[K -),-+.$" /57%"9$14,-+.$ + -07X #S:Y / :"
#/( !"#"$ %1328<#R ,-+" )6+,-+.$)6+"9$14$03@:" "9# "5
7'" "9# &5839 " "9# 8%+$22+$&'( 7 "4:k#Y4p 393 34(:3@2N2+
810N:0 " "9# :SN<"
51 %"w414<@()6+,-+.$" "9# N2+-%1+:%'5
X )6+,-+.$839>14< M*%"<@( $4Y/" "9# )6+-%1+
VX )6+>14,-+2-83,-+.$*0$1@8391"$7 )6+,-+.$" "9# N2+1"1: (8<#R
TX :/:S2<%"971$,-+.$#/()6++:-3%/($%!"#/( %",012#/(N2+" "4:; #/("
"9# 1+
xX 89 ,-+.$839>1463/%3/(%"" "9# 6"839 63 *42#/("4:k#Y4p 393
34(:3@2*0 6"7<$%,%) /$6"@ 6"7 8%+$2 :SN<" 1+
WX 89 ,-+.$ +!"%" J J
#' J
,-+.$" /5N2+"%""%?< 3#/("$2"|$!2< 36+…S%…4 :"1"$7"9:4 %"<
M$98#"%&+8391"$70[KN2+,3"|$8<#R01"$7IQu # #/<"+:" ,3,-+.$:/saD
] E] "9 % z D[IG<@(0 D] 839 :")6+%""%? @51+N2+# #/(7%,3IQ
u 8<#R6| :$"$01+K N"%""%?10# : #/(!"< 3@(< 3[IG)*+8$#
%"14210K #/(:/-014210N2+"$2"|$ :" K N2+M ) h *:X839,-+.$N2+"%",012: N2+"|$
7'N2+" $:32M %"2/'5%3 @-0M$9%14N2+"92|2+%""%? ;9 -0) [IG<@(" K
,-+.$N2+"%""%?1::1"{ $4**/< " +$ !2N2+"%"I z†*0$6 )7N2+" %v
: N2+",341M;ZR 3@2<@(*93%"u D#/(: 3,3%"w414#56:2#)6+,-+.$2/'5'8:+79
N2+"%",012: "0% %|flm1$"|$N:0%42!"8#"%&+ :<k%?R:< 1:/*/$41"232M839:/
S;M<*/$41#/(2/
! 3KJ@LM:/1, ! # 9/:=?@ANGF/O
X6 0$ !#"87+7S22 "RVVV <@( 21"$7IQ
VX8<#R,-+ 21"$7!#""'%?" /8<#R
TX6 0$ 0$*"9 /39ƒ]<"+:)1"$72:#/(7S21"$7<4O?
xX7S22$*"9 /839ƒ] "'%?" /8<#R
WX%";/"020$ 7+6 +#/(!#"87+6 0$ # #/
hX %";/N:0"020$#1:51 %"21"$78 %14
o
nX%"2IQg] J†# #/#N2+M ) VU #/63 ] "@(:@
! P 6 B 9/:= QRP
,-+.$* N# - S:!"< 32+$ %"6 @( 6 S6: V ) "9$14V $%0:
!"< 3!"#"$ %N !"< 3<S#Y*4"*<4?;S!3%8<#R" 393 34(:3@27%V ]
W ] $39 "5
:!"< 3!"#"$ % D] DhiT 8"%",-+.$"-+'%1$2/:/M$9&/279[K•xXo JX
VxdN:0:/753@21:1$ :/"9$1402 }To 839}xT 8<#R$447… ECDEF839 ]
A "9$1463,012y•K }VWVn )*+F T]H
J
X )6+• r U] • F
VX PKIV • ‹‚F‰VU]X • %0)6+3@2
` 63N2+" 3@2,3 JVhdA U:X X VWW H 839TUdA :X XVWW H "5/5,-+.$N:0:/021"$7
sEEEJJ aEEDKuI•U` 810N:0N2+1"$76< Y4839N:0N2+IEF ] E,-+.$ 7:/!" 3@2N2+
63N2+"%""%?,-+.$ %"2/'58<#R76 0%3 +$#/(V :X XW "$: !"< 3T $
3 S! !TQRP3 # 6 6 U
X "9:4 M$9,-+.$8"%" &%"9$14%"" "9# 393 34(:3@22-753@21:1$
VX 1421:,3IQŒ[KŒ J<"+:" 8<#R"971'%
TX 2 393 34(:3@2
xX 2-83)6+N2+" 3@2<"+: %1M$98#"%&+7%%")6+3@2
WX !#"O<#R87+M*%"<@()6+ "'%?"@($4Y/%"" "9# 393 34(:3@2#/(32M,-+.$
1$ 0#/(T + -01076$2:ƒEEz b#/(!"#"$ %:@(:/%"0$)6>079ƒiG -0#/(!"< 3
<S#Y*4"*7X<4?;S!3%" "9# 393 34(:3@2N:0N2+1:%;ZR#/(%6 27%%"#/(M*%"N S%
,-+.$839>14"@(%"" "9# 393 34(:3@2< $024:# V ]iD†810:/=>6 "@(%"N7'N
"%?< 3#/(!"< 3<S#Y*4"*8<#R)6+8%+N839" 3/( 393 34(:3@2 W ]iD†,-+
.$ w4Y%"" "9# @("0$:2+$6"@ 6"#/(3/(N7%%147'N:0:/=77 @(#/(79#)6+%42
ECDEF
U
8$# w414<@(<q 10N +8<#R790,-+.$%3 ƒiG!"< 3)%3++#S%" 79N2+"
:S2<%"971$,-+.$#/()6++:-3%/($%!"#/( %",012#/(N2+" "4:; #/(" "9# <@(
8$# )6+8<#R#($N "97!"< 31076$2)*+w414%,-+.$" 5€ %7%/5%3S0:
O3O 1"RN2+72"4%""'%? =>6 SM<!2< 3z Dnio 1 =>66"@)6+89 %
20$ "RUV`W__T W 10nooU`oT N2+132$3Vx *($!:
C! # ! # 9/:=?@A
C!B 3 #
X1"$7 $:-%1+ 3@26"@0$ "9% 3@2#/(4%:7%6+3@2!2)*+7+6 +#/(
V 839:/%"3 #'% 3 3%?;R%?"2 /5
`*42 3@2 0$ "9% 3@2-%1+1:1+%"
` 3#/())%% 3@21"%…3% S""7S
`*@(,-+"47 ))%% 3@21"%…3% S""7S
`uEED ,-+"47 ))%%1"%…3% S""7S8391"% uEED ,-+.$
`1"$7 $ "47 839$6:2 S 3@2
VX1"$7 $:"/"+ S""7S:/" "($…/% 2…3%3 3@6"@N:0
TX M< /3%?;9 3@2 0$ "9% 3@2,42%146"@N:0
xX)*+*S2)6+3@2#/(:/1$%" 2 nUN:" 8399 2"O7%*@5
WX 3@2 -42N:0$")6+ %4x *($!:
hX %1 #'% %"• F ;9)6+3@283963)6+3@2
nX 03@21"$76 $: +:+ 3@263%")6+3@2<@("9:4,3
C!B #
X" ‚F,0121"$7 *@( %S3 1'%,-+.$
VX 1"/:Qa <4:<R14%%"R142)6+*27
TX 793@21"$7ˆEb3@2 uB u723‚F,0122+$ "@( /#/(*27
xX 721"/:!3641)6+<"+:)*+-%1+839</<
WX 3@26:-0<4O?K  !#"87+8<#R8396+,012# #/#/(1"$77
hX 14210 3@26:-0<4O?N#/(%*28391421:#S%$7%$079N2+3@2
nX72#) 3@28%/1:6:-03@2<@(32$: /( 3+3@2,42S
_X:/"9 %"1"$7 !2)*+7+6 +#/(V %076 03@2
&%
7%%"O'%?#5T 1$ 0#/(%30$:79< $0 =>6 ,-+.$#/(" "9# 393 34(:3@2%4
2 ECDEF 5:/!% %42N2+63%63 %";R:/#55N:0"S8"N:0%42,3 /10,-+.$
7 '%42M$98#"%&+"S8" ',-+.$ /*/$41%"$4"96R=>6< 15810%42<"9S3%" 2$:"-+
839#%?9)%"2-83,-+.$#/(" "9# 393 34(:3@2 /%%";/@%427%1$,-+.$ #/(2$:"-+$:
+)7)%"" "9# 393 34(:3@2*07N:0N2+2 " "9# &5 1+ 61S#/(#)6+
,-+.$%42M$9 ECDEF2 5# %3S0: O3O 1"R7'6|$: >)%"#/(79"+
%"9$%"72%"#/(2/:/%"@( "$:"-+<@(%""/"-+"0$:%"96$0 S3%"#/(798%+=>6 $:"-+#/(
w41483+$N2+,32/:)*+) $#/83% 3/( "/"-+6" S3%")839 %%3S0: O3O 1"R<@( 8
0)6+ @(€ :" N)*+:@("9 =>68 2/$%N2+ %7%/5:/8$42#/(7972%3S0:,-+.$
<@()6+:"2-831$ N2+) "@(%"" "9# 393 34(:3@28 PE EJ bbEJ!2%")6+
$:"-+,-+.$839>148 6 $4**/< <@($ S:%"" "9# 393 34(:3@2:/%" )6+,-+.$
:/$:"-+) "@(%"" "9# 393 34(:3@2839w4141$ 07"47"-+$4Y/" "9# 0 -%1+,3
%"" "9# :%6"@+ %4N 7 ' :" 793@21"$7N2+2+$1$ #" ,33@2"$2"|$
:" "'%?8<#R<@((%""%?N2+%0#/(,-+.$79%42M$98#"%&+ %"" "S%"9$%"
2-83,-+.$#/(" "9# 393 34(:3@28 (@ 010 @(10N
V
VW1=-X1,-
M$9 393 34(:3@2%4 2A BCDEFH 6: '%"#/(,3 393 34(:3@2 %
k#Y4p:%%$0%;ZR#/(%6 2!22-7%0[KA[ E E] ^DK EH 839%3S0: O3O 1"R
!"#"$ %:/8$# O38<#RAˆ D H )%")6+393 34(:3@2210N /5
X ,-+.$,0123456$)7 •K‹yJ J CC 0[K #0% XW` VXU
VX ,-+.$,0123456$)7 •K‹yJ J CC‹FL JE 0[K #0% VXU` VXW
TX ,-+.$,0123456$)7y•K‹yJ J CC 0[K #0% X_` VXT
xX ,-+.$,0123456$)7y•K‹yJ J CC‹FL JE 0[K #0% X_` VXW
WX ,-+.$,0123456$)7 •K‹yJ J CC 0[K #0% VXU` VXW
hX ,-+.$,0123456$)7 •K‹uEbEF JCC 0[K#0% XW` VXUA" "9# 393
34(:3@2 "99$3T 2@H
nX ,-+.$,0123456$)7 •K‹uEbEF JCC ‹KFL JE 0[K#0% VXU` VXW
_X ,-+.$,0123456$)7Q•K‹yJ J CC 0[K#0% VXW` TXU
oX ,-+.$,0123456$)7Q•K‹uEbEF JCC 0[K#0% V` VXW A" "9# 393 34(:
3@2 "99$3T 2@H
UX ,-+.$,0123456$)7y•Kb 0[K#0% XW` VXUA" "9# 393 34(:3@2
"99$3T 2@H
X ,-+.$,0123456$)7y•Kb ‹KFL JE 0[K#0% XW` VXU
VX ,-+.$#/(N:0N2+,0123456$)78101+" "9# @(7%:/M$9%"1+ 6$)7,42%14
*42 ƒa E 0[K#0% XW` VXU
T
YX+Z 9/:;/:1,+<-:=+>- )[F
8$# %")6+%""%?,-+.$M$9 BC DEFƒEz)*+) gKBP ,-+.$#/( $079:/
M$9 ECDEFN2+8%0,-+.$#/(" "9# :@(:/M$92 /5
X:/0 PQi[K bEE c E A1" #/(H
VX:/%"839 %"82 M$93@2 %A1" #/(VH
! 8V+/XL/:2-H
EF J JF •QjPgjƒj• C DFF XW`VXW
s J JF ` •KEy•KE •KAuEbF FFH•
` •KAyJ JH
`y•KAyJ JH
` •KAyJ JH
`Q•KAuEbF FFH
`Q•KAyJ JH
`y• b •
•6: 61S" "9# z T 2@6"@,012%";/sK
XW`VXU
XW`VXU
X_`VXW
VXU`VXW
VXU`VXW
VXW`TXU
XW`VXU
! D12,/,=O.0H+.+;]X--=1,2
XsbE EFa F
VXu D ]F
TXgb FF
xXP J igJJ†]EFF
WX ]
hX ] ]FF
nXy i ] EJ ^
_X ]Eb†FF
oXB a D EFFbJ J
]E
! P^0H1+,+;Z/:;/:1,:-<-:>/X
Q†bE CF bbEJ
`KbDA U` W ] H
`ƒFAb H
`PE]bAx`h FH
`sEzAVx FXH
`G FEzAECD†FH
PIIA PE E]a JE]b‰JEJ H WUiL X
ƒƒPAU`WJJiL XH
[•C ] r W`U]X
B C ] rVXW`W]X
B] z DEF
xGuideline of Treatment
Suspect warfarin overdose
1.Check PT INR, CBC (1" #/(1)
2.S/S of bleeding (1" #/(2)
3.Review dose of warfarin and indication
4.Other medication, antiplatelet, NSAID
5.Underling liver, renal disease
Above therapeutic but <5.0
>5.0 but < 9.0
No bleeding
No bleeding
Admit ward
-Old age > 70 Yrs
-Poor compliance
-Previous bleeding
complication
Admit ward
-Lower dose or stop
-Monitor PT INR
-Notify resident CVT or staff
(Admit ward)
-Stop warfarin
-Monitor PT INR
-Notify
resident/staff CVT
(D/C)
-no bed
-no S/S of major
bleeding
-good complicance
education
-no Hx of bleeding
-F/U OPD early visit
-Admit
-stop warfarin
-Vitamin K 5-10 mg.
-Monitor PT INR in 24
hrs
-Notify resident or staff
CVT
Admit
-stop warfarin
-Vitamin K 10 mg.
-FFP
-Monitor PT INR & control in 24
hrs.
-Notify resident/staff CVT
D/C
F/U OPD CVT
#/()%3+#/(S26"@1"$7%
Staff 7+ N+
Lower dose
or
Stop warfarin
Major bleeding but not serious
Patient evaluation risk
Low risk High risk
-Age > 70
-Hx stroke
TIA
UGIB
-Hepato renal
failure
-On antiplatlet
Major bleeding
W>9.0
-admit ward
-stop warfarin
-vitamin K 10 mg.
-monitor PT INR
-notify resident/staff CVT
-admit
-stop warfarin
-vitamin K 10 mg.
-FFP
-monitor PT INR
-notify resident/staff CVT
-admit
-stop warfarin
-vitamin K 10 mg.
-FFP
-monitor PT INR
-notify resident/staff CVT
%";/ Intra cranial ]E
- notify staff X-Ray
-CT brain Ergent
- 14210Refer
- +Refer N:0N2+admit obsevere ICU
!21+notify staff CVT %0 <@(6 1/
10N
No bleeding Major bleeding
or Major bleeding
-resuscitation shock
-ET if ressesity
-vitamin K 10 mg.
FFP
-G/M
-notify staff/resident CVT !220$
-Admit ICU
-Life threatening bleeding
-hemodynamic unstable
-stroke
-suspect intracranial ]E
***
>20 (very high PT INR )(confirm not error) Any PT INR
h
5 %
%3S0: M *%"": !" #"$ %X % & E_12`aX-:Hb:W2Ic VWx_X
S;;k%?R# 7"4>X AVWxUHX 1+% "81$ 3@2* 42" "9# X & 3 d #
jUAHj`V
: :8<# R!" 6$)7860 "9#ON# X &% 7! d # J
Be! c VWWUX
" N<""S;X ! Be!B Ea,H1f+/2WX/,HIX !" #"$ %X VWWUX
y LƒX r jP ] jIIPjIˆP DP †‚EDjKX VUU_X 9/:;/:1,g/,/2-@+,>1=-:/H1+,1,
h+,2iL-:.@/:-Y/f1X1H1->X ] J ˆ JFsEJ †X ŽEF EbLFG CF†sJEEE
yDJ X y L X IEz jy jysJX u D KFLE X

Contenu connexe

Tendances

Proyecto científico equipo onlyfive pd g
Proyecto científico equipo onlyfive pd gProyecto científico equipo onlyfive pd g
Proyecto científico equipo onlyfive pd gonlifivepg
 
Measuring Agile Success
Measuring Agile SuccessMeasuring Agile Success
Measuring Agile Successiwmontgomery
 
ETIS09 - Black Swans and White Elephants - Presentation
ETIS09 - Black Swans and White Elephants - PresentationETIS09 - Black Swans and White Elephants - Presentation
ETIS09 - Black Swans and White Elephants - PresentationDavid Walker
 
IRM09 - What Can IT Really Deliver For BI and DW - Presentation
IRM09 - What Can IT Really Deliver For BI and DW - PresentationIRM09 - What Can IT Really Deliver For BI and DW - Presentation
IRM09 - What Can IT Really Deliver For BI and DW - PresentationDavid Walker
 
CITIA08 - Ready For Change? - Presentation
CITIA08 - Ready For Change? - PresentationCITIA08 - Ready For Change? - Presentation
CITIA08 - Ready For Change? - PresentationDavid Walker
 
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اولسلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اولأمنية وجدى
 
проект текст
проект текстпроект текст
проект текстdfcbkmtdf
 
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اولسلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اولأمنية وجدى
 
2010 NEW YORK URBAN LATINO FILM FESTIVAL 2010
2010 NEW YORK URBAN LATINO FILM FESTIVAL 20102010 NEW YORK URBAN LATINO FILM FESTIVAL 2010
2010 NEW YORK URBAN LATINO FILM FESTIVAL 2010synertainment4.0
 
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...OùSsama Elfalaki
 
القيادة وقت الازمات
القيادة وقت الازمات القيادة وقت الازمات
القيادة وقت الازمات Dr Ghaiath Hussein
 
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى أمنية وجدى
 

Tendances (20)

Liminar acp nasf
Liminar acp nasfLiminar acp nasf
Liminar acp nasf
 
LAB3-REPORT
LAB3-REPORTLAB3-REPORT
LAB3-REPORT
 
Slownik
SlownikSlownik
Slownik
 
Proyecto científico equipo onlyfive pd g
Proyecto científico equipo onlyfive pd gProyecto científico equipo onlyfive pd g
Proyecto científico equipo onlyfive pd g
 
Measuring Agile Success
Measuring Agile SuccessMeasuring Agile Success
Measuring Agile Success
 
ETIS09 - Black Swans and White Elephants - Presentation
ETIS09 - Black Swans and White Elephants - PresentationETIS09 - Black Swans and White Elephants - Presentation
ETIS09 - Black Swans and White Elephants - Presentation
 
IRM09 - What Can IT Really Deliver For BI and DW - Presentation
IRM09 - What Can IT Really Deliver For BI and DW - PresentationIRM09 - What Can IT Really Deliver For BI and DW - Presentation
IRM09 - What Can IT Really Deliver For BI and DW - Presentation
 
3rdchapter
3rdchapter3rdchapter
3rdchapter
 
Omg Bedeschi Company Profile
Omg Bedeschi Company ProfileOmg Bedeschi Company Profile
Omg Bedeschi Company Profile
 
CITIA08 - Ready For Change? - Presentation
CITIA08 - Ready For Change? - PresentationCITIA08 - Ready For Change? - Presentation
CITIA08 - Ready For Change? - Presentation
 
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اولسلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثالث الابتدائى ترم اول
 
Our Methodology
Our MethodologyOur Methodology
Our Methodology
 
проект текст
проект текстпроект текст
проект текст
 
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اولسلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اول
سلسلة الليالى العشر فى الرياضيات للصف الثانى الابتدائى ترم اول
 
2010 NEW YORK URBAN LATINO FILM FESTIVAL 2010
2010 NEW YORK URBAN LATINO FILM FESTIVAL 20102010 NEW YORK URBAN LATINO FILM FESTIVAL 2010
2010 NEW YORK URBAN LATINO FILM FESTIVAL 2010
 
Actions that vietnamese dislike
Actions that vietnamese dislikeActions that vietnamese dislike
Actions that vietnamese dislike
 
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...
النظريات التفسيرية للعلاقات الدولية بين التكيف و النغير في ظل تحولات العالم م...
 
القيادة وقت الازمات
القيادة وقت الازمات القيادة وقت الازمات
القيادة وقت الازمات
 
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى
بوكلت الدراسات الإجتماعية للصف الرابع الابتدائى للترم الثانى
 
Full Report
Full ReportFull Report
Full Report
 

Similaire à Km การดูแลผู้ป่วยได้รับยาละลายลิ่มเลือดในผู้ป่วยผ่าตัดลิ้นหัวใจ

Representing the curriculum symposium
Representing the curriculum symposiumRepresenting the curriculum symposium
Representing the curriculum symposiumHelen Beetham
 
ArcLight Cinemas
ArcLight CinemasArcLight Cinemas
ArcLight CinemasMike Jensen
 
NETWORK REBRAND - pitch presentation (short version)
NETWORK REBRAND  - pitch presentation (short version)NETWORK REBRAND  - pitch presentation (short version)
NETWORK REBRAND - pitch presentation (short version)Stefano Di Ceglie
 
DiplomadoIABMex_Equipo6
DiplomadoIABMex_Equipo6DiplomadoIABMex_Equipo6
DiplomadoIABMex_Equipo6jorgemacias23
 
Historiografía de la educación comie selección
Historiografía de la educación comie selecciónHistoriografía de la educación comie selección
Historiografía de la educación comie selecciónnada
 
Nearby Startup Pitch for SUU 2013 conference
Nearby Startup Pitch for SUU 2013 conferenceNearby Startup Pitch for SUU 2013 conference
Nearby Startup Pitch for SUU 2013 conferenceAdam Nemeth
 
Justin Hughes Press Release
Justin Hughes Press Release Justin Hughes Press Release
Justin Hughes Press Release Justin Michael
 
NGAGE-About us/UX
NGAGE-About us/UXNGAGE-About us/UX
NGAGE-About us/UXhspoeneman
 
NGAGEnow
NGAGEnowNGAGEnow
NGAGEnowNGAGE
 
Adapt, Collaborate, Innovate
Adapt, Collaborate, InnovateAdapt, Collaborate, Innovate
Adapt, Collaborate, InnovateJim Smurro
 
Requirements specification desingyourown_v2
Requirements specification desingyourown_v2Requirements specification desingyourown_v2
Requirements specification desingyourown_v2caramurf
 
Skytide by the Numbers
Skytide by the NumbersSkytide by the Numbers
Skytide by the NumbersPatrick Hurley
 

Similaire à Km การดูแลผู้ป่วยได้รับยาละลายลิ่มเลือดในผู้ป่วยผ่าตัดลิ้นหัวใจ (20)

Representing the curriculum symposium
Representing the curriculum symposiumRepresenting the curriculum symposium
Representing the curriculum symposium
 
ArcLight Cinemas
ArcLight CinemasArcLight Cinemas
ArcLight Cinemas
 
NETWORK REBRAND - pitch presentation (short version)
NETWORK REBRAND  - pitch presentation (short version)NETWORK REBRAND  - pitch presentation (short version)
NETWORK REBRAND - pitch presentation (short version)
 
DiplomadoIABMex_Equipo6
DiplomadoIABMex_Equipo6DiplomadoIABMex_Equipo6
DiplomadoIABMex_Equipo6
 
27thchapter
27thchapter27thchapter
27thchapter
 
Thai Alcoholic Beverages Regulations 2011
Thai Alcoholic Beverages Regulations 2011Thai Alcoholic Beverages Regulations 2011
Thai Alcoholic Beverages Regulations 2011
 
Historiografía de la educación comie selección
Historiografía de la educación comie selecciónHistoriografía de la educación comie selección
Historiografía de la educación comie selección
 
Nearby Startup Pitch for SUU 2013 conference
Nearby Startup Pitch for SUU 2013 conferenceNearby Startup Pitch for SUU 2013 conference
Nearby Startup Pitch for SUU 2013 conference
 
Justin Hughes Press Release
Justin Hughes Press Release Justin Hughes Press Release
Justin Hughes Press Release
 
NGAGE-About us/UX
NGAGE-About us/UXNGAGE-About us/UX
NGAGE-About us/UX
 
NGAGEnow
NGAGEnowNGAGEnow
NGAGEnow
 
Adapt, Collaborate, Innovate
Adapt, Collaborate, InnovateAdapt, Collaborate, Innovate
Adapt, Collaborate, Innovate
 
Sani 2013 satisfaction.
Sani 2013   satisfaction.Sani 2013   satisfaction.
Sani 2013 satisfaction.
 
referente
referentereferente
referente
 
Requirements specification desingyourown_v2
Requirements specification desingyourown_v2Requirements specification desingyourown_v2
Requirements specification desingyourown_v2
 
a mirada dos espazos
a mirada dos espazosa mirada dos espazos
a mirada dos espazos
 
Skytide by the Numbers
Skytide by the NumbersSkytide by the Numbers
Skytide by the Numbers
 
Ppt wkc 18 novembre
Ppt wkc 18 novembrePpt wkc 18 novembre
Ppt wkc 18 novembre
 
33rdchapter
33rdchapter33rdchapter
33rdchapter
 
Commerce extérieur france 3e trimestre 2010
Commerce extérieur france 3e trimestre 2010Commerce extérieur france 3e trimestre 2010
Commerce extérieur france 3e trimestre 2010
 

Plus de sucheera Leethochawalit

ตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdf
ตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdfตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdf
ตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdfsucheera Leethochawalit
 
เอกสารประกอบการเรียนวิชาโภชนบำบัด
เอกสารประกอบการเรียนวิชาโภชนบำบัดเอกสารประกอบการเรียนวิชาโภชนบำบัด
เอกสารประกอบการเรียนวิชาโภชนบำบัดsucheera Leethochawalit
 
แนวเวชปฏิบัติโรคพิษสุนัขบ้า
แนวเวชปฏิบัติโรคพิษสุนัขบ้าแนวเวชปฏิบัติโรคพิษสุนัขบ้า
แนวเวชปฏิบัติโรคพิษสุนัขบ้าsucheera Leethochawalit
 
แนวทางการรักษาโรคหลอดเลือดสมองอุดตัน
แนวทางการรักษาโรคหลอดเลือดสมองอุดตันแนวทางการรักษาโรคหลอดเลือดสมองอุดตัน
แนวทางการรักษาโรคหลอดเลือดสมองอุดตันsucheera Leethochawalit
 
ตำราเภสัชกรรมไทย
ตำราเภสัชกรรมไทย ตำราเภสัชกรรมไทย
ตำราเภสัชกรรมไทย sucheera Leethochawalit
 
แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์
แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์ แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์
แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์ sucheera Leethochawalit
 
หลักทั่วไปในการให้วัคซีน
หลักทั่วไปในการให้วัคซีน หลักทั่วไปในการให้วัคซีน
หลักทั่วไปในการให้วัคซีน sucheera Leethochawalit
 

Plus de sucheera Leethochawalit (11)

ตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdf
ตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdfตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdf
ตารางคำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ 2566 .pdf
 
คู่มือโภชนากร
คู่มือโภชนากรคู่มือโภชนากร
คู่มือโภชนากร
 
เอกสารประกอบการเรียนวิชาโภชนบำบัด
เอกสารประกอบการเรียนวิชาโภชนบำบัดเอกสารประกอบการเรียนวิชาโภชนบำบัด
เอกสารประกอบการเรียนวิชาโภชนบำบัด
 
Chemo ebookสงขลา
Chemo ebookสงขลาChemo ebookสงขลา
Chemo ebookสงขลา
 
แนวเวชปฏิบัติโรคพิษสุนัขบ้า
แนวเวชปฏิบัติโรคพิษสุนัขบ้าแนวเวชปฏิบัติโรคพิษสุนัขบ้า
แนวเวชปฏิบัติโรคพิษสุนัขบ้า
 
แนวทางการรักษาโรคหลอดเลือดสมองอุดตัน
แนวทางการรักษาโรคหลอดเลือดสมองอุดตันแนวทางการรักษาโรคหลอดเลือดสมองอุดตัน
แนวทางการรักษาโรคหลอดเลือดสมองอุดตัน
 
ตำราเภสัชกรรมไทย
ตำราเภสัชกรรมไทย ตำราเภสัชกรรมไทย
ตำราเภสัชกรรมไทย
 
แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์
แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์ แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์
แนวทางการดูแลรักษาผู้ป่วยถูกงูกัดและได้รับพิษจากสัตว์
 
หลักทั่วไปในการให้วัคซีน
หลักทั่วไปในการให้วัคซีน หลักทั่วไปในการให้วัคซีน
หลักทั่วไปในการให้วัคซีน
 
Antidote pocket guide v.3
Antidote pocket guide v.3Antidote pocket guide v.3
Antidote pocket guide v.3
 
antidote y57
antidote y57antidote y57
antidote y57
 

Dernier

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 

Dernier (20)

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 

Km การดูแลผู้ป่วยได้รับยาละลายลิ่มเลือดในผู้ป่วยผ่าตัดลิ้นหัวใจ

  • 1.
  • 2.
  • 3. !"#"$ %&'()*+),-+.$#/(,012 3456$)7839&0:3456$)7,-+.$1+" "9# "99$3 1+" "9# 132*/$41) ;9#/( )!"< 3:/=>62+%"" 2 #)6+,-+.$1+ %4%6 283963%3 +:/ =>67%%"%3:"%?&5)!"< 37%" "9# %46"@1(%$0 2A BCDEF D GDDEFH &'( I J KFL#/( >#)6+%42M$98#"%&+,-+.$ N:032M 2 5 O3%"":7'72%47%"":%"72%"$:"-+) ,-+.$#/(:/N2+" '5<@()*+ 8$# "0$:%) PIQO3O 1"R ,-+.$ % M*%"":839 S"%"":6$)7 ;9,-+72# TU% VWWT
  • 4. V ! "# !$% & ' X เ<@( 8$# )%"2-83,-+.$#/(N2+" 393 34(:3@2%4 2)6+:/"94#Y4M< ,-+.$ 32M32M$98#"%&+ VX <@( 8$# )6+7+6 +#/()6 0$ O3%"":#" %;ZR0[KA [ E E] ^DK EH TX <@( 8$# )%""%?839%"< 3<@(8%+=>68 6 $4**/< (# X ,-+.$63,0123456$)7#/(7 1+" "9# 393 34(:3@2N2+-%1+ :" $ S:0[KN2+1:%;ZR#/(%6 2AM )!"< 3$ S:[K T 839,-+.$ 63,012:%%$0V_ $:K` D] $ S:[K WH :/8$# %"2-83,-+.$#/(:/M$9 ECDEF 0[K:%%$0%;ZR#/(%6 2 VX 32M$98#"%&+7%%"" "9# 393 34(:3@2%4 2#/("S8" N2+8%0 I a ]E TX ,-+.$#/(N2+" 393 34(:3@2 :"72%"% =>6N2+2+$1 !272%3S0:2-83 ,-+.$8 6 $4**/< APE EJ bbEJH !)" ` 1"[Kc T 63,0123456$)7)!"< 3%;ZR%6 2c VUdA7 $,-+.$ [Kc T e 7 $,-+.$#/(N2+" 393 34(:3@2: !"< 3)810392@ H ` 1"[Kc W 63,0123456$)7:%%$0V_ $%3:K ` D] c VUdA7 $,-+.$[K cW e7 $,-+.$#/(N2+" 393 34(:3@2: K` D] )!"< 3810392@ H ` 1"%"%42M$98#"%&+#/("S8",37% ECDEF ` I a ]E c UdA7 $,-+.$#/(%42 %"e7 $,-+.$#/(N2+" 393 34(: 3@2: K` D] 63,0123456$)7810392@ H ` %42753@21:1$ 3@2 %1:N"f=cVUdA7 $,-+.$#/(:/%"e7 $,-+.$#/( N2+" 393 34(:3@2: !"< 363,0123456$)7810392@ H
  • 5. T *+,-./001,2 gKBP DO3%"":%0,012AhiV jhiTH DO3%"":63,012"99$4%k1A[IGH DO3%"":63,012"99<%flmAnioH 6+,012ABKH M*%"": # & 34 %563 "0$:42 X<X #$/O%24p !*14$q < ?RO38<#R S; @5AIrBH X<X *-O%24p %?:O 14p O38<#R S; $ArsH X X <"6:<" <*"-# 6$6 + %"< 36+,012 S;3441 X X :<" !1t94 6$6 + %"< 3O3%"": S;%47Ar H ;9< 3O3O 1"R uF bJJ S;%47Ar H %47%"": v6: e:/8$# 72%"=>6)%")6+%"2-83"%?,-+.$#/(N2+" 393 34(:3@2%4 263,0123456$)7 ! %")*+%"9$%"72%"$:"-+)%"8%+N =>6,-+.$N2+" 393 34(:3@2%4 263 ,0123456$)7#/(+:"%?)!"< 3 80= "0$:"+ "/ #/ " "S 9#+%3 "0$:w414 $2,3
  • 6. x ! $ S:8397268$# w414:@(%42=>67%!"8#"%&+63,-+.$" "9# 393 34(: 3@2%4 2),-+.$63,0123456$)7 7 %"72%"$:"-+ryArEz D ] ] H %"9$%"#/(2 4%""0$:%!2,-+w414 6"@6 0$ 0) R%"<@("+839)*+$:"-+)%"<q )6+:/S;M<839%42,33<YR2/'5 !2 $ -0N%%"<q 6"@,-+w414 839<q { $:"-+ 6 0$ 6"@ R%"2 5%" 72%"$:"-+7' :" :)*+ "@(:@ 06 '()%"8%+=>6 6 0$ #/(%42'5)6+N2+ %"9$%"72%"$:"-+#/(2/839:/%""/"-+"0$:%"96$0 S3%"#/(798%+=>6 !2*0$%3(%" 6"@ "96R$:"-+7%,-+*/($*>8397%1" -0:@6"@ % "$4*%": $:"-+#/(S3%" :" N )*+)%"# <@(8%+N =>6N2+%"83% 3/( "/"-+%) "@(#/(%6 279%42"9!*R10,-+#/(2 "9 %";R6"@"9 =>68 2/$% :")*+$:"-+#/(N2+N8%+=>6N2+0 -%1+"$2"|$839 %42"9!*R-S210,-+" "4%"10N 6$6 +%3S0: O3O 1"RN2+%6 2! "97 })2+%" ,0123456$)7WUU" i},-+.$630/57 1+" "9# 393 34(:3@2 010 @(132N <@( v%N:0)6+%4234(:3@2N S21)"9 N63$/ "0% @(7% 2 #/()*+:/63 *42839 63 2*0 2#/()*+VjTjxjW ] 7'#)6+,-+.$%42$:,42<327%%"" "9# @(7%7N:0 N2+3@:" "9# 6"@" "9# &5#)6+%42=>6 %4 2!2)*+$4Y/1"$72-0[K%3S0: 15 N$+$00[K[Kc T %;ZR VUd7%%"~4142@ :%" :%|N2+•WXn d2@ %S:M< YR%|N2+ •xXh d2@ :/ :%|N2+•o d7% 414#/(:/828$!+:323 @(:7%S3%" %3S0: 1"96 %839)6+$: )%"2-83,-+.$%3S0:2%30$!2"0$:%8%+=>6 72#8$# ~414%" $4Y/" "9# k#Y4 ,3 / %"%42M$98#"%&+!2N2+" $:"0$::@#57%8<#R < 3M* %% M< 2839%!M* %" v6: <@()6+,-+.$" "9# 0 -%1+839 < : >146"@,-+2-83,-+.$)%+3*42*0$ </(3/5 1@6"@$ S%%%"" "9# )6+N2+,3 2/:%'5 0$) "@(%"9$%"72%"=>6)6+%""%?< 3N2+72#8$# %""%?#5 8<#R < 3"$:'#/:2-83)6+:/%" N)*+%,-+.$N2+)63 € %";R<@()6+,-+.$ 32M21$ 0#/( 79 10N /5
  • 7. W ! 8 6 9/:;/:1,+<-:=+>- # # ?@A ,-+.$<O6>4 SVo }63,012y•KJQ•Kb :@($#/(h <k?M :VWW 63,012 $ < =>6 ‚EzI DJE b 1+)*+"@(*0$< S6$)7A[uPH 637%5V $ $#/(_ <k?M : VWW ,-+.$ %"2/'5 :" B gQQa839z E "@(*0$< S6$)7A[uPH %N2+"4(:" "9# 393 34(:3@2$#/(o <k?M :VWW !28<#R)6+"4(:" "9# W ] B $ #/(VU<k?M :VWW N2+T ] B $#/(V <k?M :VWW N2+T ] B " T $ 791"$7,3 [K$#/(VV <k?M :VWW $3UhXUU X ,3%"79[K•oXV ,-+.$N:0:/%"8#"%&+ a D 7%$$9)2€ %"2-83"%?#/(N2+") [IG X BaFCM$9a D VX " 8<#R"#" # #/8<#R(%""%?,-+.$N2+" • r ]bX • jƒƒPV 839)6+ B 393 34(:3@2V $ TX 1"$7,3[K<@(Kb $3 _XUU X VT <k?M :VWW A1:%;ZR%6 2Kb 6 [K M ) Vx *:XH ,3N2+[K•Xn " 8<#R(%""%?)6+"4(:" "9# 393 34(:3@2)6:0 xX ,-+.$ %"#S3[K -0) %;ZR#/(%6 28<#R(+,-+.$ %7%[IGN<%"%?1$#/( Dnio 7+6 +#/(N2+010+:-3"@(%"" "9# 393 34(:3@2 ,-+.$%42 2 <@()6+7+6 +#/( D„v"9$,-+.$10 @(10N "S,-+.$ :"76 0%3 +N2+7%%"„v"9$N:0< [KPEE /% #'#&#!% B ,-+.$" /5,3[K -810N:0:/%"82 M$98#"%&+ *0:/3@2 %1:N"f=:@(:/%" 8"f=63B gQQa&'( w4%4"4#/(N:0N8$# 2/$%,-+.$ 7:/0#/(1(%$0/5%|N2+,3%" 1"$7 7N:0 7"4< 3 [IGN2+" $0:/%"1"$7 1:8$# ~414#/(%6 2 -083+$@ X Kb %"1"$7/%"5" ,3[K•oXV #0"58"% VX S3%"#/(793@2 2#%?9*0%"2-23@2 %:7% %"""7S)0Qa 3@2 01"$7 N:0:/8$# #/(*27 7%42%" lm "v%%"IE 3@2*0$ "4:k#Y4p TX )63%%" [IG79793@201"$71 *+!21"$7<"+:%#5IuI uEEDs uEEDIE839PQiPQQ!22-23@2VUJJ)0Qa 01"$7‚ax Qa %")0Qa N:0:/%"%6 2 $0)0QaN6 %083963!281039Qa79:/"v%%"8|1$ 3@2 -02 /5 `Qa IuI:/"g JJ JJ*0$)6+3@2N:0IE ` Qa uEEDs :/"sED]ƒED v%%"8|1$ 3@2839v%%")*+513 :|23@282
  • 8. h ` Qa uEEDIEN:0:/"9N" ` QaPQiPQQ:/sED]I v%%"8|1$ 3@2 xX /%"92|6 '(#/(0 "4: 61S#)6+%420[K,42%14@M$9 "0% ,-+.$%/($%!" 1#/(7#)6+%42k#Y4p "393 34(:3@2 3/(83 7%%"1"$7‚a#/(82 :""M<%" # 1!21"$7u a ,3:%%$0UUU&'(%4%$00%14:% 7#)6+!"1/#/()*+)%"8|1$ 3@2#/(1 "+ '5 -0) M<N:0<"+:)*+ %"8|1$ 3@27'*+%$0%14 7 C! X :/%"1"$7IE ])6:0#S%"5#/(< $00[K ,-+.$ -%40%14839N:0:/%" 8#"%&+!2%"793@2)6:0 VX %"2-23@27% 01"$7[K1+2-23@2<@()6+80)7$0N:0:/ b lm!2 2-23@2 %VUJJ%02-23@201"$7 TX 72#8$# %"""7SQa‚a:@(:/%"1"$73@2IE]b ‚a#S%"5"/322 /5 TX )0QauEEDJE TXV )0Qa PQiPQQ TXT )0QaIuI TXx )0QauEEDs xX 8<#R7)*+EF 393 34(:3@2323)" #/(:/M$91$ 6"@:/!"1"0$:2+$ ! D 6 9/:;/:1,+<-:=+>- # # ?@AE F-G/=.1HI ,-+.$6>4 Sx_ }63,012y•KJ‚ DJE J E :@($#/(VU%"%~ :VWx :/=>6 : !"< 3!"#"$ %:@(VT %S:M< YRVWxT 2+$ %" L8 08" <-2N:0N2+ 8<#R(1"$7[K,3Xx 83901"$7IQu ,3< I a JE8<#R)6+%""%?2+$ 839 % M< 2 -0!"< 3 W $ %"2/'5,-+.$"-+'%1$2/<-2N2+8 8|8"8<#R76 0 %3 +$#/(o :/ :VWxT ,-+.$:!"< 3"5/5$#/(x <k?M :VWW 2+$ %"&':3%0:!"< 3T $ <-2N:0 *2:/3@(N+7/ < 753@21:8 ` '!"< 3#/(6+…S%…479[K,3•nXh " 8<#R # #/
  • 9. n %""%?)6+6• r ]b• 8390# IQu ,3< saD ] E] 0 +[IG<@( )6+%"2-83"%?M$9…S%…483914210K ,-+.$N!"< 3@(<@("%?10) "@(!"# : #/( 71+N2+"%",012 7+6 +#/([IGN2+14210<@(K ,-+.$!2)*+%"9$%"2 /5 X < 3[J z D14210O-R@( "<@(14210!"< 3+ / #S%!"< 3#/( :",012: N2+!214210#/39!"< 3"4(:7%!"< 3)%3+/%0 *0!"< 3<"9 (%3+!"< 3 "O"2-"!"< 3*3"9# !"< 3M-:4<3 VX 8<#R$"6"@8<#R7+ N+79 S" 39 /2%8<#R !"< 3#/(14210 TX %";/ ,-+.$ 1""9% SM<1+14210 *X <@()6+*0$6!"< 3#/(79" K ,-+.$ xX<-2S%>14!28<#R839< 3#/(2-83<@("+ $: +)7%";/1+K ,-+.$N!" < 3@(839*/587 4#Y4)%"70 0"%?< 3 4#Y41+ %2 "9% SM< 839"9% :) !"< 3"{ 3 WX %";/>14N:0:/=>6# %"4 :"14210!"< 3 %* <@(K ,-+.$N"%?10 @(N2+<@()6+,-+.$N2+"%""%?#/("$2"|$ hX :@(14210N2+2 4%"1:51 %"K 1:%148390,-+.$N!2" ]a J <"+:% 7+6 +#/([IGN%" K 0,-+.$N!"< 3M-:4<3A"$:"99$3)%"14210 K N2+M ) h *($!:H # & F-;-: X )0gQQaEƒE†‡FJ 839EˆQa VX )6+ ‰_ ]X • F 637%5 ‰_ ] • #S%_ *: TX Š ‰WU]X • #S%_ *:X xX ƒƒPV • WX EaFC•isjis &%IF /5:"14210K N2+!2!"< 3M-:4<3",-+.$ @(7%,-+.$:/1""9% SM<#/(!"< 3M-:4<363K ,-+.$N "%""%?1083+$7+6 +#/([IGN2+!#"1421:,3%" "%?)$10:#" $0,-+.$N2+"%",012: saD ] E] 63,0122/'5•isFa 2/ =77S <%flm -0 DY"":2"-+'%1$2/<-2SN2+8 ` 8|8"2/ %";//5< $00[K -!2 :< YR% %"8#"%&+#/(%42'57%"9 %";R 1$ 0#/( #)6+7+6 +#/([IGN2+1"$7[K&5T "5!2 793@27%1$,-+.$ @ N2+$00[K -7"4
  • 10. _ $4"96R 61S$0#N:'%42[K -),-+.$" /57%"9$14,-+.$ + -07X #S:Y / :" #/( !"#"$ %1328<#R ,-+" )6+,-+.$)6+"9$14$03@:" "9# "5 7'" "9# &5839 " "9# 8%+$22+$&'( 7 "4:k#Y4p 393 34(:3@2N2+ 810N:0 " "9# :SN<" 51 %"w414<@()6+,-+.$" "9# N2+-%1+:%'5 X )6+,-+.$839>14< M*%"<@( $4Y/" "9# )6+-%1+ VX )6+>14,-+2-83,-+.$*0$1@8391"$7 )6+,-+.$" "9# N2+1"1: (8<#R TX :/:S2<%"971$,-+.$#/()6++:-3%/($%!"#/( %",012#/(N2+" "4:; #/(" "9# 1+ xX 89 ,-+.$839>1463/%3/(%"" "9# 6"839 63 *42#/("4:k#Y4p 393 34(:3@2*0 6"7<$%,%) /$6"@ 6"7 8%+$2 :SN<" 1+ WX 89 ,-+.$ +!"%" J J #' J ,-+.$" /5N2+"%""%?< 3#/("$2"|$!2< 36+…S%…4 :"1"$7"9:4 %"< M$98#"%&+8391"$70[KN2+,3"|$8<#R01"$7IQu # #/<"+:" ,3,-+.$:/saD ] E] "9 % z D[IG<@(0 D] 839 :")6+%""%? @51+N2+# #/(7%,3IQ u 8<#R6| :$"$01+K N"%""%?10# : #/(!"< 3@(< 3[IG)*+8$# %"14210K #/(:/-014210N2+"$2"|$ :" K N2+M ) h *:X839,-+.$N2+"%",012: N2+"|$ 7'N2+" $:32M %"2/'5%3 @-0M$9%14N2+"92|2+%""%? ;9 -0) [IG<@(" K ,-+.$N2+"%""%?1::1"{ $4**/< " +$ !2N2+"%"I z†*0$6 )7N2+" %v : N2+",341M;ZR 3@2<@(*93%"u D#/(: 3,3%"w414#56:2#)6+,-+.$2/'5'8:+79 N2+"%",012: "0% %|flm1$"|$N:0%42!"8#"%&+ :<k%?R:< 1:/*/$41"232M839:/ S;M<*/$41#/(2/ ! 3KJ@LM:/1, ! # 9/:=?@ANGF/O X6 0$ !#"87+7S22 "RVVV <@( 21"$7IQ VX8<#R,-+ 21"$7!#""'%?" /8<#R TX6 0$ 0$*"9 /39ƒ]<"+:)1"$72:#/(7S21"$7<4O? xX7S22$*"9 /839ƒ] "'%?" /8<#R WX%";/"020$ 7+6 +#/(!#"87+6 0$ # #/ hX %";/N:0"020$#1:51 %"21"$78 %14
  • 11. o nX%"2IQg] J†# #/#N2+M ) VU #/63 ] "@(:@ ! P 6 B 9/:= QRP ,-+.$* N# - S:!"< 32+$ %"6 @( 6 S6: V ) "9$14V $%0: !"< 3!"#"$ %N !"< 3<S#Y*4"*<4?;S!3%8<#R" 393 34(:3@27%V ] W ] $39 "5 :!"< 3!"#"$ % D] DhiT 8"%",-+.$"-+'%1$2/:/M$9&/279[K•xXo JX VxdN:0:/753@21:1$ :/"9$1402 }To 839}xT 8<#R$447… ECDEF839 ] A "9$1463,012y•K }VWVn )*+F T]H J X )6+• r U] • F VX PKIV • ‹‚F‰VU]X • %0)6+3@2 ` 63N2+" 3@2,3 JVhdA U:X X VWW H 839TUdA :X XVWW H "5/5,-+.$N:0:/021"$7 sEEEJJ aEEDKuI•U` 810N:0N2+1"$76< Y4839N:0N2+IEF ] E,-+.$ 7:/!" 3@2N2+ 63N2+"%""%?,-+.$ %"2/'58<#R76 0%3 +$#/(V :X XW "$: !"< 3T $ 3 S! !TQRP3 # 6 6 U X "9:4 M$9,-+.$8"%" &%"9$14%"" "9# 393 34(:3@22-753@21:1$ VX 1421:,3IQŒ[KŒ J<"+:" 8<#R"971'% TX 2 393 34(:3@2 xX 2-83)6+N2+" 3@2<"+: %1M$98#"%&+7%%")6+3@2 WX !#"O<#R87+M*%"<@()6+ "'%?"@($4Y/%"" "9# 393 34(:3@2#/(32M,-+.$ 1$ 0#/(T + -01076$2:ƒEEz b#/(!"#"$ %:@(:/%"0$)6>079ƒiG -0#/(!"< 3 <S#Y*4"*7X<4?;S!3%" "9# 393 34(:3@2N:0N2+1:%;ZR#/(%6 27%%"#/(M*%"N S% ,-+.$839>14"@(%"" "9# 393 34(:3@2< $024:# V ]iD†810:/=>6 "@(%"N7'N "%?< 3#/(!"< 3<S#Y*4"*8<#R)6+8%+N839" 3/( 393 34(:3@2 W ]iD†,-+ .$ w4Y%"" "9# @("0$:2+$6"@ 6"#/(3/(N7%%147'N:0:/=77 @(#/(79#)6+%42 ECDEF
  • 12. U 8$# w414<@(<q 10N +8<#R790,-+.$%3 ƒiG!"< 3)%3++#S%" 79N2+" :S2<%"971$,-+.$#/()6++:-3%/($%!"#/( %",012#/(N2+" "4:; #/(" "9# <@( 8$# )6+8<#R#($N "97!"< 31076$2)*+w414%,-+.$" 5€ %7%/5%3S0: O3O 1"RN2+72"4%""'%? =>6 SM<!2< 3z Dnio 1 =>66"@)6+89 % 20$ "RUV`W__T W 10nooU`oT N2+132$3Vx *($!: C! # ! # 9/:=?@A C!B 3 # X1"$7 $:-%1+ 3@26"@0$ "9% 3@2#/(4%:7%6+3@2!2)*+7+6 +#/( V 839:/%"3 #'% 3 3%?;R%?"2 /5 `*42 3@2 0$ "9% 3@2-%1+1:1+%" ` 3#/())%% 3@21"%…3% S""7S `*@(,-+"47 ))%% 3@21"%…3% S""7S `uEED ,-+"47 ))%%1"%…3% S""7S8391"% uEED ,-+.$ `1"$7 $ "47 839$6:2 S 3@2 VX1"$7 $:"/"+ S""7S:/" "($…/% 2…3%3 3@6"@N:0 TX M< /3%?;9 3@2 0$ "9% 3@2,42%146"@N:0 xX)*+*S2)6+3@2#/(:/1$%" 2 nUN:" 8399 2"O7%*@5 WX 3@2 -42N:0$")6+ %4x *($!: hX %1 #'% %"• F ;9)6+3@283963)6+3@2 nX 03@21"$76 $: +:+ 3@263%")6+3@2<@("9:4,3 C!B # X" ‚F,0121"$7 *@( %S3 1'%,-+.$ VX 1"/:Qa <4:<R14%%"R142)6+*27 TX 793@21"$7ˆEb3@2 uB u723‚F,0122+$ "@( /#/(*27 xX 721"/:!3641)6+<"+:)*+-%1+839</< WX 3@26:-0<4O?K !#"87+8<#R8396+,012# #/#/(1"$77 hX 14210 3@26:-0<4O?N#/(%*28391421:#S%$7%$079N2+3@2 nX72#) 3@28%/1:6:-03@2<@(32$: /( 3+3@2,42S _X:/"9 %"1"$7 !2)*+7+6 +#/(V %076 03@2
  • 13. &% 7%%"O'%?#5T 1$ 0#/(%30$:79< $0 =>6 ,-+.$#/(" "9# 393 34(:3@2%4 2 ECDEF 5:/!% %42N2+63%63 %";R:/#55N:0"S8"N:0%42,3 /10,-+.$ 7 '%42M$98#"%&+"S8" ',-+.$ /*/$41%"$4"96R=>6< 15810%42<"9S3%" 2$:"-+ 839#%?9)%"2-83,-+.$#/(" "9# 393 34(:3@2 /%%";/@%427%1$,-+.$ #/(2$:"-+$: +)7)%"" "9# 393 34(:3@2*07N:0N2+2 " "9# &5 1+ 61S#/(#)6+ ,-+.$%42M$9 ECDEF2 5# %3S0: O3O 1"R7'6|$: >)%"#/(79"+ %"9$%"72%"#/(2/:/%"@( "$:"-+<@(%""/"-+"0$:%"96$0 S3%"#/(798%+=>6 $:"-+#/( w41483+$N2+,32/:)*+) $#/83% 3/( "/"-+6" S3%")839 %%3S0: O3O 1"R<@( 8 0)6+ @(€ :" N)*+:@("9 =>68 2/$%N2+ %7%/5:/8$42#/(7972%3S0:,-+.$ <@()6+:"2-831$ N2+) "@(%"" "9# 393 34(:3@28 PE EJ bbEJ!2%")6+ $:"-+,-+.$839>148 6 $4**/< <@($ S:%"" "9# 393 34(:3@2:/%" )6+,-+.$ :/$:"-+) "@(%"" "9# 393 34(:3@2839w4141$ 07"47"-+$4Y/" "9# 0 -%1+,3 %"" "9# :%6"@+ %4N 7 ' :" 793@21"$7N2+2+$1$ #" ,33@2"$2"|$ :" "'%?8<#R<@((%""%?N2+%0#/(,-+.$79%42M$98#"%&+ %"" "S%"9$%" 2-83,-+.$#/(" "9# 393 34(:3@28 (@ 010 @(10N
  • 14. V VW1=-X1,- M$9 393 34(:3@2%4 2A BCDEFH 6: '%"#/(,3 393 34(:3@2 % k#Y4p:%%$0%;ZR#/(%6 2!22-7%0[KA[ E E] ^DK EH 839%3S0: O3O 1"R !"#"$ %:/8$# O38<#RAˆ D H )%")6+393 34(:3@2210N /5 X ,-+.$,0123456$)7 •K‹yJ J CC 0[K #0% XW` VXU VX ,-+.$,0123456$)7 •K‹yJ J CC‹FL JE 0[K #0% VXU` VXW TX ,-+.$,0123456$)7y•K‹yJ J CC 0[K #0% X_` VXT xX ,-+.$,0123456$)7y•K‹yJ J CC‹FL JE 0[K #0% X_` VXW WX ,-+.$,0123456$)7 •K‹yJ J CC 0[K #0% VXU` VXW hX ,-+.$,0123456$)7 •K‹uEbEF JCC 0[K#0% XW` VXUA" "9# 393 34(:3@2 "99$3T 2@H nX ,-+.$,0123456$)7 •K‹uEbEF JCC ‹KFL JE 0[K#0% VXU` VXW _X ,-+.$,0123456$)7Q•K‹yJ J CC 0[K#0% VXW` TXU oX ,-+.$,0123456$)7Q•K‹uEbEF JCC 0[K#0% V` VXW A" "9# 393 34(: 3@2 "99$3T 2@H UX ,-+.$,0123456$)7y•Kb 0[K#0% XW` VXUA" "9# 393 34(:3@2 "99$3T 2@H X ,-+.$,0123456$)7y•Kb ‹KFL JE 0[K#0% XW` VXU VX ,-+.$#/(N:0N2+,0123456$)78101+" "9# @(7%:/M$9%"1+ 6$)7,42%14 *42 ƒa E 0[K#0% XW` VXU
  • 15. T YX+Z 9/:;/:1,+<-:=+>- )[F 8$# %")6+%""%?,-+.$M$9 BC DEFƒEz)*+) gKBP ,-+.$#/( $079:/ M$9 ECDEFN2+8%0,-+.$#/(" "9# :@(:/M$92 /5 X:/0 PQi[K bEE c E A1" #/(H VX:/%"839 %"82 M$93@2 %A1" #/(VH ! 8V+/XL/:2-H EF J JF •QjPgjƒj• C DFF XW`VXW s J JF ` •KEy•KE •KAuEbF FFH• ` •KAyJ JH `y•KAyJ JH ` •KAyJ JH `Q•KAuEbF FFH `Q•KAyJ JH `y• b • •6: 61S" "9# z T 2@6"@,012%";/sK XW`VXU XW`VXU X_`VXW VXU`VXW VXU`VXW VXW`TXU XW`VXU ! D12,/,=O.0H+.+;]X--=1,2 XsbE EFa F VXu D ]F TXgb FF xXP J igJJ†]EFF WX ] hX ] ]FF nXy i ] EJ ^ _X ]Eb†FF oXB a D EFFbJ J ]E ! P^0H1+,+;Z/:;/:1,:-<-:>/X Q†bE CF bbEJ `KbDA U` W ] H `ƒFAb H `PE]bAx`h FH `sEzAVx FXH `G FEzAECD†FH PIIA PE E]a JE]b‰JEJ H WUiL X ƒƒPAU`WJJiL XH [•C ] r W`U]X B C ] rVXW`W]X B] z DEF
  • 16. xGuideline of Treatment Suspect warfarin overdose 1.Check PT INR, CBC (1" #/(1) 2.S/S of bleeding (1" #/(2) 3.Review dose of warfarin and indication 4.Other medication, antiplatelet, NSAID 5.Underling liver, renal disease Above therapeutic but <5.0 >5.0 but < 9.0 No bleeding No bleeding Admit ward -Old age > 70 Yrs -Poor compliance -Previous bleeding complication Admit ward -Lower dose or stop -Monitor PT INR -Notify resident CVT or staff (Admit ward) -Stop warfarin -Monitor PT INR -Notify resident/staff CVT (D/C) -no bed -no S/S of major bleeding -good complicance education -no Hx of bleeding -F/U OPD early visit -Admit -stop warfarin -Vitamin K 5-10 mg. -Monitor PT INR in 24 hrs -Notify resident or staff CVT Admit -stop warfarin -Vitamin K 10 mg. -FFP -Monitor PT INR & control in 24 hrs. -Notify resident/staff CVT D/C F/U OPD CVT #/()%3+#/(S26"@1"$7% Staff 7+ N+ Lower dose or Stop warfarin Major bleeding but not serious Patient evaluation risk Low risk High risk -Age > 70 -Hx stroke TIA UGIB -Hepato renal failure -On antiplatlet Major bleeding
  • 17. W>9.0 -admit ward -stop warfarin -vitamin K 10 mg. -monitor PT INR -notify resident/staff CVT -admit -stop warfarin -vitamin K 10 mg. -FFP -monitor PT INR -notify resident/staff CVT -admit -stop warfarin -vitamin K 10 mg. -FFP -monitor PT INR -notify resident/staff CVT %";/ Intra cranial ]E - notify staff X-Ray -CT brain Ergent - 14210Refer - +Refer N:0N2+admit obsevere ICU !21+notify staff CVT %0 <@(6 1/ 10N No bleeding Major bleeding or Major bleeding -resuscitation shock -ET if ressesity -vitamin K 10 mg. FFP -G/M -notify staff/resident CVT !220$ -Admit ICU -Life threatening bleeding -hemodynamic unstable -stroke -suspect intracranial ]E *** >20 (very high PT INR )(confirm not error) Any PT INR
  • 18. h 5 % %3S0: M *%"": !" #"$ %X % & E_12`aX-:Hb:W2Ic VWx_X S;;k%?R# 7"4>X AVWxUHX 1+% "81$ 3@2* 42" "9# X & 3 d # jUAHj`V : :8<# R!" 6$)7860 "9#ON# X &% 7! d # J Be! c VWWUX " N<""S;X ! Be!B Ea,H1f+/2WX/,HIX !" #"$ %X VWWUX y LƒX r jP ] jIIPjIˆP DP †‚EDjKX VUU_X 9/:;/:1,g/,/2-@+,>1=-:/H1+,1, h+,2iL-:.@/:-Y/f1X1H1->X ] J ˆ JFsEJ †X ŽEF EbLFG CF†sJEEE yDJ X y L X IEz jy jysJX u D KFLE X